Chk-336, a first-in-class orally administered ldh inhibitor: safety, pk and target engagement in a first-in-human phase 1 healthy volunteer study

Vincent Tong,Brian Schwartz, Chun Lam,John Knight,Sonia Fargue, David A. Wagner,Harvey Wong, Lei Wang, Hetal Kocinsky, Valerie Fauvelle,Andrew King

NEPHROLOGY DIALYSIS TRANSPLANTATION（2023）

Cited 0|Views7

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined